Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on December 7, 2012. The filing discloses the execution of a new executive employment agreement with Gregory S. Skinner, the Company's Vice President of Finance and Administration and Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to executive compensation:
- Annual Base Salary: $310,000 (unchanged from current salary).
- Term: Effective January 1, 2013, through December 31, 2015.
- Equity: Eligible for grants under the 2009 Stock Incentive Plan.
Material Changes
The material change reported is the formalization of Mr. Skinner's employment terms via a new agreement. There are no reported changes to the Company's financial position or operations in this document.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, outlook, or management commentary regarding business performance. However, it outlines specific contractual contingencies and risks related to executive turnover:
- Termination without Cause/Good Reason: Triggers a severance payment equal to 100% of annual base salary, one-year acceleration of unvested equity, and continued health insurance premiums.
- Change of Control: If termination occurs within two years of a change of control, severance increases to 150% of annual base salary, and all unvested equity immediately vests.
- Restrictive Covenants: Mr. Skinner is restricted from soliciting employees, consultants, licensors, or customers for two years post-termination.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Review the full text of Exhibit 10.37 for detailed terms of the employment agreement.
- Assess the potential impact of the change-of-control provisions on future M&A transactions.
- Confirm the status of the Company's 2009 Stock Incentive Plan regarding available equity for future grants.